SUPPLIERS
Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.
Certificate Number : CEP 2025-274 - Rev 00
Issue Date : 2026-02-06
Type : Chemical
Substance Number : 1444
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36506
Submission : 2022-06-16
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28449
Submission : 2014-06-16
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 42963
Submission : 2025-11-20
Status : Active
Type : II
Certificate Number : R1-CEP 2016-283 - Rev 01
Issue Date : 2023-01-12
Type : Chemical
Substance Number : 1444
Status : Valid
NDC Package Code : 57449-010
Start Marketing Date : 2025-08-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Hwail Pharmaceutical Co., Ltd.
Registration Date : 2025-12-17
Registration Number : 20251217-211-J-2091
Manufacturer Name : AVESTA PHARMA PVT. LTD
Manufacturer Address : Plot No. 2, Gut No 189/1, 189/2, 191/2, 191/6, 194, 165/3, 166, 167, 168, 169 AT Post-Alonde, Tal-Vikramgad, Palghar 421303 Maharashtra State, India
Certificate Number : CEP 2006-085 - Rev 06
Issue Date : 2026-01-29
Type : Chemical
Substance Number : 1444
Status : Valid
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
Certificate Number : CEP 2024-418 - Rev 00
Issue Date : 2025-03-26
Type : Chemical
Substance Number : 1444
Status : Valid
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 59044-0007
Start Marketing Date : 2006-03-01
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (22.7kg/22.7kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59044-0027
Start Marketing Date : 2006-03-01
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (907kg/907kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59044-0017
Start Marketing Date : 2018-06-21
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Certificate Number : CEP 2009-392 - Rev 02
Issue Date : 2026-01-21
Type : Chemical
Substance Number : 1444
Status : Valid
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]LISTED SUPPLIERS
FINISHED DOSAGE FORMULATIONS
FDF DOSSIERS SUPPLIERS
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : CLARITHROMYCIN
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 65154
Country : US
Patented : No
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Drug : VALGANCICLOVIR HYDROCHLORIDE
Dosage Form : TABLET; ORAL
Application Number : 200790
Country : US
Patented : No
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Drug : IBUPROFEN
Dosage Form : TABLET; ORAL
Application Number : 78329
Country : US
Patented : No
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
Drug : OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
Dosage Form : TABLET; ORAL
Application Number : 209281
Country : US
Patented : No
Drug : QUETIAPINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 206252
Country : US
Patented : No
Drug : QUETIAPINE FUMARATE
Dosage Form : TABLET; ORAL
Application Number : 201504
Country : US
Patented : No
Drug : PANTOPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 91231
Country : US
Patented : No
Drug : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 211291
Country : US
Patented : No
Drug : ABIRATERONE ACETATE
Dosage Form : TABLET; ORAL
Application Number : 209227
Country : US
Patented : No
Drug : SIMVASTATIN
Dosage Form : TABLET; ORAL
Application Number : 76052
Country : US
Patented : No
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EXCIPIENTS BY APPLICATIONS
Topical
Lubricants Glidants
Emulsifying Agents
Fillers Diluents Binders
Thickeners And Stabilizers
Parenteral
Solubilizers
Surfactant Foaming Agents
Film Formers Plasticizers
Digital Content
DATA COMPILATION #PharmaFlow
MARKET PLACE
